The Ever-Expanding Association Between Rheumatologic Diseases and Tuberculosis

Franco‐Paredes, Carlos; Díaz-Borjón, Alejandro; Senger, Mark A.; Barragan, Lorena; Leonard, Michael

doi:10.1016/j.amjmed.2005.10.063

Cited by 50 publications

(31 citation statements)

References 68 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some authors have identified a higher frequency of EPTB, compared with the frequency of PTB, among patients on particular immunosuppressive therapies [36] or have advocated increased suspicion of EPTB in rheumatologic patients [37]. Others have investigated possible differences between EPTB and PTB in genetic or immune-mediated predispositions [38,39].…”

Section: Discussionmentioning

confidence: 97%

Epidemiology of Extrapulmonary Tuberculosis in the United States, 1993–2006

Peto

Pratt

Harrington³

et al. 2009

CLIN INFECT DIS

593

439

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 97%

Epidemiology of Extrapulmonary Tuberculosis in the United States, 1993–2006

Peto

Pratt

Harrington³

et al. 2009

CLIN INFECT DIS

593

439

View full text Add to dashboard Cite

show abstract

“…The association of tuberculosis (TB) and rheumatological diseases is well known [6], [7]. Mycobacterium tuberculosis can directly infect the musculoskeletal system, as in this case; vice versa, patients with rheumatological disease are prone to develop TB because of their own underlying or drug-induced immunosuppression status.…”

Section: Discussionmentioning

confidence: 99%

An undiagnosed pleural effusion with surprising consequences

Casalini

Cusmano²,

Sverzellati

et al. 2017

Respiratory Medicine Case Reports

View full text Add to dashboard Cite

We present the case of a 43-year-old Italian woman with a left undiagnosed pleural effusion, which in subsequent months presented a clinically unexpected evolution with the appearance at first of a right wrist tenosynovitis and subsequently a bilateral lung involvement caused by M. Tuberculosis.With this case report, we would like to underline the importance of making a correct diagnosis of any pleural effusion as soon as possible by at least a thoracocentesis. If untreated, tuberculosis may easily disseminate to other organs. Some considerations and suggestions for antibiotic treatment of pleural effusion will also be given, since many antibiotics have some anti-tuberculosis effect and may delay the diagnosis of this infectious disease.

show abstract

“…Erythema nodosum has occurred following vaccination; however, vaccines are an uncommon etiology for this reactive erythema (Table 1) [13–24]. To the best of my knowledge, the currently described woman is the first individual in whom erythema nodosum has been reported following vaccination with Tdap.…”

Section: Discussionmentioning

confidence: 99%

“… a Bacille–Calmette–Guerin (BCG) vaccine, a live attenuated vaccine derived from attenuated strains of Mycobacterium bovis, is used to prevent tuberculosis [13]. A retrospective study of etiologic factors associated with erythema nodosum in children was performed; BCG vaccination was the related etiology in 1 of 45 patients [14].…”

Section: Discussionmentioning

confidence: 99%

Combined Reduced-Antigen Content Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccine-Related Erythema Nodosum: Case Report and Review of Vaccine-Associated Erythema Nodosum

Cohen

2013

Dermatol Ther (Heidelb)

View full text Add to dashboard Cite

BackgroundVaccination programs reduce the morbidity and mortality of diphtheria, pertussis, and tetanus. Erythema nodosum is a reactive erythema that can be associated with infections, drugs, and many conditions. The new onset of erythema nodosum after receiving vaccination is uncommon.PurposeCombined reduced-antigen content tetanus, diphtheria, and acellular pertussis (Tdap) vaccine-associated erythema nodosum is described and the reports of vaccine-related erythema nodosum are summarized.MethodsThe clinical features of a 39-year-old woman who developed erythema nodosum after receiving Tdap vaccine are reported. Using the PubMed database, an extensive literature search was performed on erythema nodosum, vaccine, and vaccination.ResultsTdap, the most commonly used booster vaccine against tetanus, diphtheria, and pertussis, is well tolerated in all age groups. Local injection-site reactions are the most common adverse events, whereas headache, fatigue, gastrointestinal symptoms, and fever are the most frequent systemic events. Erythema nodosum has not previously been reported in patients who have received Tdap vaccine. The patient developed erythema nodosum within 48 h after receiving Tdap vaccine; her symptoms cleared and nearly all skin lesions resolved within 2 weeks after initiating oral treatment with ibuprofen, fexofenadine, and prednisone. Vaccine-associated erythema nodosum has previously been reported following vaccination for cholera, hepatitis B, human papillomavirus, malaria, rabies, small pox, tuberculosis, and typhoid.ConclusionVaccine-associated erythema nodosum is uncommon. Erythema nodosum occurring after Tdap vaccination is a rare, yet potential, adverse effect.

show abstract

The Ever-Expanding Association Between Rheumatologic Diseases and Tuberculosis

Cited by 50 publications

References 68 publications

Epidemiology of Extrapulmonary Tuberculosis in the United States, 1993–2006

Epidemiology of Extrapulmonary Tuberculosis in the United States, 1993–2006

An undiagnosed pleural effusion with surprising consequences

Combined Reduced-Antigen Content Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccine-Related Erythema Nodosum: Case Report and Review of Vaccine-Associated Erythema Nodosum

Contact Info

Product

Resources

About